Рет қаралды 8,488
GETECCU
Lucía Madero y Alfonso Elosua revisan el artículo "Vedolizumab to prevent postoperative recurrence of Crohn's disease (REPREVIO): a multicentre, double-blind, randomised, placebo-controlled trial"